Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 6,649

Document Document Title
WO/2018/202525A1
The invention is in the technical field of insect control and relates to novel phenoxyethanamine derivatives, their production and use for controlling pests and in particular insecticide-resistant pests such as mosquitoes and cockroaches.  
WO/2018/199146A1
Provided is a novel method for producing amide compounds at high stereochemical selectivity. This method for producing amide compounds is provided with an amidation step for reacting an aminoester compound represented by general formula ...  
WO/2018/106221A1
Sulfide scavengers useful to reduce sulfide concentration in fluid streams and methods of using these scavengers. The scavengers comprise oil soluble reaction products of formaldehyde/N-substituted hydroxylamines and can be used to reduc...  
WO/2018/094334A1
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed.  
WO/2018/060354A1
The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them, wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and ot...  
WO/2017/170885A1
Crystals of (2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzo yl)(methyl)amino)-N-hydroxy-N',2-dimethylmalonamide having diffraction peaks at diffraction angles (2θ) of 3.8±0.2°, 7.7±0.2°, and 10.8±0.2°, and the like or...  
WO/2017/154019A1
The present invention relates to an improved process for the preparation of 1,3-bis(2-chloroethyl)-1 -nitrosourea compound of formual-1 which is represented by the following structural formula:  
WO/2017/106520A1
Disclosed are compounds of formulas I and II, in which R, R0, R1-R4, R7-R10, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds. The compounds and pharmaceutical compositions are for use in ...  
WO/2017/024009A1
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and...  
WO/2017/012757A1
The invention relates to an improved method for the preparation of alkylsalicylaldehyde or its corresponding metallic salts. The invention also relates to a method for the preparation of alkylsalicylaldoxime by reacting said alkylsalicyl...  
WO/2017/006295A1
Disclosed are compounds having the formula: (I) wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP...  
WO/2016/043001A1
Provided is a novel compound used in solar cells. This compound is an organic/inorganic mixed compound indicated by formula (I). R1Y1N+H2(Y2H)M1X1 3 … (I) (In the formula (I): R1 indicates a C1-C6 alkyl group, a C3-C6 alkenyl group, or...  
WO/2016/023510A1
Provided is a micromolecule compound as represented by structural formula (I). The product of the present invention in various concentrations and dosages can achieve an obvious change in the growth period of hairs, promoting the growth o...  
WO/2015/199367A1
An aspect of the present invention provides a styrenated phenol compound characterized in that styrenated phenol is combined with a hydrazine or diaminoalkane compound. The styrenated phenol compound prevents discoloration in the use wit...  
WO/2015/141956A1
A precursor compound, according to one embodiment of the present invention, is represented by R1(C6H5)NSiH3, wherein R1 is any one selected from a halide group, hydrogen, a C1-C4 alkyl group, a C4-C7 cyclic alkyl group, a phenyl group or...  
WO/2015/117146A1
β-Substituted -amino acids, β-substituted γ-amino acid derivatives, and β-substituted γ-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted γ-amino acid derivatives and ...  
WO/2015/114031A1
The present invention relates to primary hydroxylamines, to pharmaceutical compositions comprising them, to their use in the treatment and/or prevention of bacterial infections and to their use in the prevention of formation or reduction...  
WO/2015/117147A1
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and...  
WO/2015/080936A1
The disclosure provides improved processes for preparing N-methylhydroxylamine and N-methylhydroxylamine hydrochloride.  
WO/2015/061630A2
A compound is provided, comprising: an Fe(III)-binding or an Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; a drug; and an Fe(III) to Fe(II) reduction triggered linker bound to the drug and th...  
WO/2015/019928A1
The present invention relates to a novel synthesis method that is capable of producing an optically active binaphthyldiamine derivative, under conditions whereby the binaphthyldiamine derivative can be produced more safely and efficientl...  
WO/2015/001436A1
The present invention relates to alkoxyamines of general formula (I), and to compounds of general formula (lla), (lIb), (lIc), (IId), IIe), (Ilf) or (Ilg), as such and for the treatment of cancers.  
WO/2014/206855A1
The present invention relates to a process for the enantioselective preparation of the compound of formula (lb), which process comprises a) reducing the (E)- or (Z)-form of a compound of formula (II), with an enantioselective reagent to ...  
WO/2014/207071A1
The present invention relates to novel strobilurine type compounds, to compositions comprising at least one such compound, to methods for combating phytopathogenic fungi, to the use of such compounds and to seeds coated with at least one...  
WO/2014/197991A8
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/197991A1
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/159508A1
The present disclosure provides methods for separating ketones and alcohols. In one embodiment, the methods and compositions disclosed are useful in separating cyclohexanol from cyclohexanone. In one embodiment, cyclohexanone is converte...  
WO/2014/064706A1
Provided herein are novel, commercially viable and industrially advantageous processes for the preparation of Agomelatine or a salt thereof, in high yield and purity, using novel intermediates.  
WO/2013/184645A3
Novel phenyl-glyoxal based anti-citrulline probes and methods of synthesis are provided. Methods of use, such as, the development of methods for monitoring substrate citrullination over time; for identifying citrullinated proteins from c...  
WO/2013/120874A1
The present application relates to a process for preparing chloroamines which can be used as precursors for syntheses of fine chemicals and active ingredients from pharmaceuticals and/or agriculture, by reaction of secondary amines of th...  
WO/2013/104774A1
The present invention relates to the preparation of optically resolved chiral compounds of β-amino acid type active pharmaceutical ingredients (API), more specifically to β-aminobutyryl substituted compounds and especially β-aminobuty...  
WO/2013/086373A1
The present invention relates to novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides, to facilitate the cellular uptake an...  
WO/2013/077855A1
A method for the stabilization of an aqueous choline hydroxide solution includes optionally, adding a first stabilizer of a dithionite salt or a dialkylhydroxylamine to an aqueous solution containing reactants that will produce an aqueou...  
WO/2013/076190A1
A method for the stabilization of an aqueous choline hydroxide solution includes, optionally adding a first stabilizer of a dithionite salt and/or a dialkylhydroxylamine to an aqueous solution containing reactants that will produce an aq...  
WO/2013/049280A3
The disclosure relates to compounds, pharmaceutical compositions, and methods of treating or preventing disease. In certain embodiments, the disclosure relates to methods of treating an infection or cancer comprising administering a phar...  
WO/2013/007054A1
The present invention relates a method for preparation of ketoxime compound, comprising: feeding a ketone compound, hydrogen peroxide, water, and ammonia into a reactor for contact reaction under the conditions of oximation reaction of k...  
WO/2012/163815A1
The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin.  
WO/2012/118216A1
The present invention addresses the problem of providing an auxin biosynthesis inhibitor superior to L-AOPP. The foregoing problem can be solved by a compound of general formula (I) (in the formula, R1-R5 and X are as set forth in the sp...  
WO/2012/063931A1
The object of the present invention is to provide a compound useful as an intermediate for the production of a pyrazinecarboxamide derivative such as 6-fluoro-3-hydroxy-2-pyrazinecarboxamide. The present invention provides a pyrazino[2,3...  
WO/2011/147690A1
Compounds of Formula (I) wherein R1 is C1-C4alkyl or C1 -C4 haloalkyl; R2 is C1-C4alkyl; R3 is hydrogen or halogen; R4 is hydrogen, C1-C4alkyl or C1-C4halogenalkyl; R5 is hydrogen, halogen, C1-C4alkyl or C1-C4halogenalkyl; R6 is hydrogen...  
WO/2011/056620A8
Cationic surfactants of formula I in which R1, R2, R3, R4, R5, R6, X and n are as defined are useful in a variety of applications, including in cleaners, detergents and personal care products, particularly shampoos and conditioners.  
WO/2011/056620A1
Cationic surfactants of formula I in which R1, R2, R3, R4, R5, R6, X and n are as defined are useful in a variety of applications, including in cleaners, detergents and personal care products, particularly shampoos and conditioners.  
WO/2011/045355A1
Compounds of formula (I), in which the substituents are as defined in claim 1, are suitable for use as microbiocides.  
WO/2011/023645A1
Compounds of formula (I) in which the substituents are as defined in claim 1, are suitable for use as microbiocides.  
WO/2010/116140A1
There is provided a process for the preparation of a compound of formula (II), wherein R1, R2, R3 and R4 are as described in the description. Such compounds may, for example, be useful intermediates in the synthesis of drugs such as Dron...  
WO/2010/116140A8
There is provided a process for the preparation of a compound of formula (II), wherein R1, R2, R3 and R4 are as described in the description. Such compounds may, for example, be useful intermediates in the synthesis of drugs such as Dron...  
WO/2010/106071A1
Compounds of formula (I) in which the substituents are as defined in claim 1, are suitable for use as microbiocides.  
WO/2010/069266A1
The heterocyclic nitrogenous or oxygenous compounds of formula (A), (B), (C) or (D) formed from dialdehydes, their optical isomers, cis- and trans- isomers, or agrochemically acceptable salts, their preparation methods, agrochemical comp...  
WO/2010/063700A8
Compounds of formula (I) in which the substituents are as defined in claim 1,are suitable for use as microbiocides.  
WO/2010/063700A2
Compounds of formula (I) in which the substituents are as defined in claim 1,are suitable for use as microbiocides.  

Matches 1 - 50 out of 6,649